|Home | Speakers | Agenda | Venue | Posters | Register|
EXAMINING SCIENTIFIC, TECHNOLOGICAL, REGULATORY & BUSINESS TRENDS & STRATEGIES TO ADVANCE PROTEIN AND ANTIBODY THERAPEUTICS & AID BIOSIMILAR DEVELOPMENT
The Biosimilars market is currently worth almost $20 billion and is anticipated to grow way beyond $55 Billion post 2020. This growth is down to numerous factors including current positive pipeline development, companies looking to take advantage of the highly lucrative third wave of biosimilar opportunity as well as government efforts worldwide to reduce healthcare costs.
This interactive meeting will provide the opportunity to take home cutting edge strategies, regulatory guidelines, CMC considerations, case study examples, developments and methods to allow you to further your research, keep abreast of your competitors and stay on top of the latest biosimilar development in Europe, US and Emerging Markets.
This will be achieved through adding solution based presentations, exhibitors and networking breaks to poster presentation sessions, expert led case study presentations and incisive Q&A panel discussions from a 30 strong speaker faculty examining topics including:
Development Strategy, Market Access and Commercialization
Overcoming Regulation & CMC Hurdles for Biosimilar Development
Also co-located with the Biologics Congress 2016
For a more detailed synopsis please visit the Agenda page.
Get speaker resources as they are released.....
Also to receive updates and get special offers before anyone else,
please complete the newsletter form below.
Content Sponsors and Exhibitors
Copyright: Global Engage Ltd. Registered in England. No: 6950636